Sunlight To Pursue Omnisense Bone Sonometer Multi-Site Indications In U.S.
This article was originally published in The Gray Sheet
Executive Summary
Sunlight Ultrasound Technologies plans to pursue FDA approval of multi-site indications for its Omnisense ultrasound bone sonometer following Jan. 20 premarket approval for assessing skeletal fragility along the distal radius (wrist) bone.